InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,344.00
(
0.41%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
86.11
(
0.81%
)
Bitcoin
61,325.19
(
-0.46%
)
Post# of 29174
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

PennyStockInvestor

Send PM Follow Ignore
Followers 183
Posts 7856
Boards Moderated 0
Alias Born 02/06/2010

PennyStockInvestor

Re: PennyStockInvestor post# 1735

Sunday, 03/30/2014 11:16:30 PM

Sunday, March 30, 2014 11:16:30 PM

Post# of 29174

After receiving a patent approval, David's previous pharmaceutical company, Praxis Pharmaceuticals, received an equity investment from Rothschild Bioscience Unit, a division of the worldwide Rothschild Group.

Source: http://www.thefreelibrary.com/Patent+Approval+by+Rothschild+Tele-Conference+Planned+for+July+15,...-a055155413

If people see David's affiliation with the world-renowned Rothschild Group, but fail to see the potential trajectory of Supreme Pharmaceuticals, they'll never know a good investment when they see it.

Supreme Pharmaceuticals President and CEO David Stadnyk

http://www.supremepharmaceuticals.com/index.php/corporate

SPRWF is a gold mine and David & Co. will soon be passing out enormous nuggets to their shareholders.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up